Drugs / Chengdu Kanghua
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03774628 | Aug 2018 → Feb 2019 | rabies | Jiangsu Province Centers for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chengdu Kanghua | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03774628 ↗ |
| Known as | Kanghua vaccine | “A total of 1200 subjects aged 10-60 years were randomly assigned trial group (Kanghua vaccine group, 600 participants) and control groups (Pasteur vaccine group, 600 participants).” NCT03774628 ↗ |
| Modality | Vaccine | “A rabies vaccine (human diploid cell) for human use, Freeze-dried” NCT03774628 ↗ |